These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Tetrahydroberberine blocks ATP-sensitive potassium channels in dopamine neurons acutely-dissociated from rat substantia nigra pars compacta. Wu C; Yang K; Liu Q; Wakui M; Jin GZ; Zhen X; Wu J Neuropharmacology; 2010 Dec; 59(7-8):567-72. PubMed ID: 20804776 [TBL] [Abstract][Full Text] [Related]
26. The autosomal recessive juvenile Parkinson disease gene product, parkin, interacts with and ubiquitinates synaptotagmin XI. Huynh DP; Scoles DR; Nguyen D; Pulst SM Hum Mol Genet; 2003 Oct; 12(20):2587-97. PubMed ID: 12925569 [TBL] [Abstract][Full Text] [Related]
27. The antioxidant drink effective microorganism-X (EM-X) pre-treatment attenuates the loss of nigrostriatal dopaminergic neurons in 6-hydroxydopamine-lesion rat model of Parkinson's disease. Datla KP; Bennett RD; Zbarsky V; Ke B; Liang YF; Higa T; Bahorun T; Aruoma OI; Dexter DT J Pharm Pharmacol; 2004 May; 56(5):649-54. PubMed ID: 15142343 [TBL] [Abstract][Full Text] [Related]
29. mtDNA clock runs out for dopaminergic neurons. Manfredi G Nat Genet; 2006 May; 38(5):507-8. PubMed ID: 16642013 [No Abstract] [Full Text] [Related]
30. The effect of repetitive transcranial magnetic stimulation on a model rat of Parkinson's disease. Yang X; Song L; Liu Z Neuroreport; 2010 Mar; 21(4):268-72. PubMed ID: 20087233 [TBL] [Abstract][Full Text] [Related]
31. [Parkinson's disease: what have we learned from the genes responsible for familial forms?]. Corti O; Brice A Med Sci (Paris); 2003 May; 19(5):613-9. PubMed ID: 12836396 [TBL] [Abstract][Full Text] [Related]
32. Expression of ErbB4 in substantia nigra dopamine neurons of monkeys and humans. Zheng Y; Watakabe A; Takada M; Kakita A; Namba H; Takahashi H; Yamamori T; Nawa H Prog Neuropsychopharmacol Biol Psychiatry; 2009 Jun; 33(4):701-6. PubMed ID: 19336245 [TBL] [Abstract][Full Text] [Related]
33. A possible role for humoral immunity in the pathogenesis of Parkinson's disease. Orr CF; Rowe DB; Mizuno Y; Mori H; Halliday GM Brain; 2005 Nov; 128(Pt 11):2665-74. PubMed ID: 16219675 [TBL] [Abstract][Full Text] [Related]
34. Parkin gene therapy for alpha-synucleinopathy: a rat model of Parkinson's disease. Yamada M; Mizuno Y; Mochizuki H Hum Gene Ther; 2005 Feb; 16(2):262-70. PubMed ID: 15761265 [TBL] [Abstract][Full Text] [Related]
35. Dopaminergic dysfunction in unrelated, asymptomatic carriers of a single parkin mutation. Inzelberg R; Hattori N; Mizuno Y Neurology; 2005 Dec; 65(11):1843. PubMed ID: 16344545 [No Abstract] [Full Text] [Related]